揭示了铁死在黑色素瘤中的复杂作用和机制
Rui Tao1, Yichuan Li2, Song Gong3
1Department of Plastic Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei Province, China.
Biochimica et biophysica acta. Reviews on cancer
|December 7, 2024
概括
铁,一种依赖于铁的细胞死亡,在黑色素瘤治疗中表现有前途. 了解铁亡机理和生物标志物可以为这种侵入性癌症带来新的诊断和治疗策略.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
背景情况:
- 黑色素瘤是一种黑色素细胞的恶性瘤,患病率正在上升.
- 铁亡是一种独特的被编程细胞死亡形式,由铁的积累和脂质过氧化驱动.
- 铁亡在形态上是由线粒体变化所表现的.
研究的目的:
- 审查铁死在黑色素瘤发展中的作用和调节机制.
- 为了探索黑色素瘤中与铁死相关的免疫调节.
- 讨论黑色素瘤中ferroptosis的诊断和治疗潜力.
主要方法:
- 关于铁亡和黑色素瘤研究的文献综述.
- 对铁亡生物标志物及其在黑色素瘤进展中的表达模式的分析.
- 检查ferroptosis诱导对黑色素瘤生长和免疫治疗的影响.
主要成果:
- 铁酶在调节黑色素瘤发展方面发挥着重要作用.
- 与铁亡相关的生物标志物表明瘤的敏感性,并提供诊断/治疗点.
- 诱导铁亡会抑制黑色素瘤的生长,并提高免疫治疗的疗效.
结论:
- 铁化是黑色素瘤的关键调节剂,对诊断和治疗有影响.
- 基于铁质的疗法为黑色素瘤管理提供了新的策略.
- 对铁亡机制的进一步研究将促进黑色素瘤治疗选择.
更多相关视频
08:02Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
Published on: May 14, 2021
5.5K
09:21Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts
Published on: February 23, 2024
856
相关概念视频
Necrosis
4.4K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.4K
Electron Transport Chain: Complex I and II
12.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
12.2K
Overview of Cell Death
7.1K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.1K
Translocation of Proteins into the Mitochondria
3.1K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
3.1K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
